144 related articles for article (PubMed ID: 11064444)
41. Comparison of injection site pain and injection site reactions in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a or 1b.
Baum K; O'Leary C; Coret Ferrer F; Klímová E; Procházková L; Bugge J;
Mult Scler; 2007 Nov; 13(9):1153-60. PubMed ID: 17967843
[TBL] [Abstract][Full Text] [Related]
42. Interferon beta-1a in relapsing multiple sclerosis: four-year extension of the European IFNbeta-1a Dose-Comparison Study.
Clanet M; Kappos L; Hartung HP; Hohlfeld R;
Mult Scler; 2004 Apr; 10(2):139-44. PubMed ID: 15124757
[TBL] [Abstract][Full Text] [Related]
43. A pilot trial of combination therapy with mitoxantrone and interferon beta-1b using monthly gadolinium-enhanced magnetic resonance imaging.
Jeffery DR; Chepuri N; Durden D; Burdette J
Mult Scler; 2005 Jun; 11(3):296-301. PubMed ID: 15957510
[TBL] [Abstract][Full Text] [Related]
44. Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial.
Ravnborg M; Sørensen PS; Andersson M; Celius EG; Jongen PJ; Elovaara I; Bartholomé E; Constantinescu CS; Beer K; Garde E; Sperling B
Lancet Neurol; 2010 Jul; 9(7):672-80. PubMed ID: 20542736
[TBL] [Abstract][Full Text] [Related]
45. Serum auto antibodies presence in multiple sclerosis patients treated with beta-interferon 1a and 1b.
Speciale L; Saresella M; Caputo D; Ruzzante S; Mancuso R; Calvo MG; Guerini FR; Ferrante P
J Neurovirol; 2000 May; 6 Suppl 2():S57-61. PubMed ID: 10871787
[TBL] [Abstract][Full Text] [Related]
46. [Open trial of the effectiveness of interferon beta 1a (Avonex) in multiple sclerosis. Clinical assessment using motor coordination tests].
Selmaj K; Członkowska A; Kwieciński H; Losy J; Podemski R; Stelmasiak Z
Neurol Neurochir Pol; 2003; 37(6):1163-83. PubMed ID: 15174231
[TBL] [Abstract][Full Text] [Related]
47. [Development of binding antibodies to interferon-beta during treatment of multiple sclerosis with different types of interferon-beta].
Bartosik-Psujek H; Mitosek-Szewczyk K; Belniak E; Stelmasiak Z
Pol Merkur Lekarski; 2004 Jul; 17(97):28-32. PubMed ID: 15559606
[TBL] [Abstract][Full Text] [Related]
48. Short communication: treatment of relapsing-remitting multiple sclerosis 96 patients with IFN-beta 1b: results of a 6-year follow-up.
Bencsik K; Füvesi J; Fricska-Nagy Z; Rajda C; Losonczi E; Török M; Vécsei L
J Interferon Cytokine Res; 2006 Feb; 26(2):96-100. PubMed ID: 16487029
[TBL] [Abstract][Full Text] [Related]
49. Health-related quality of life as an independent predictor of long-term disability for patients with relapsing-remitting multiple sclerosis.
Baumstarck K; Pelletier J; Butzkueven H; Fernández O; Flachenecker P; Idiman E; Stecchi S; Boucekine M; Auquier P;
Eur J Neurol; 2013 Jun; 20(6):907-14, e78-9. PubMed ID: 23347258
[TBL] [Abstract][Full Text] [Related]
50. [Interferon-beta 1a in relapsing-remitting multiple sclerosis. First report of a Mexican population].
León C; Violante A; Arriada N; Santana HR; Corona T
Rev Neurol; 2000 Dec 1-15; 31(11):1019-22. PubMed ID: 11190865
[TBL] [Abstract][Full Text] [Related]
51. The quality-of-life effects of interferon beta-1b in multiple sclerosis. An extended Q-TWiST analysis.
Schwartz CE; Coulthard-Morris L; Cole B; Vollmer T
Arch Neurol; 1997 Dec; 54(12):1475-80. PubMed ID: 9400356
[TBL] [Abstract][Full Text] [Related]
52. [Treatment of relapsing-remitting multiple sclerosis with recombinant interferon-beta preparations].
Mäurer M; Gold R; Toyka KV; Rieckmann P
Nervenarzt; 2001 Feb; 72(2):108-16. PubMed ID: 11256144
[TBL] [Abstract][Full Text] [Related]
53. Glatiramer acetate in treatment-naïve and prior interferon-beta-1b-treated multiple sclerosis patients.
Zwibel HL;
Acta Neurol Scand; 2006 Jun; 113(6):378-86. PubMed ID: 16674604
[TBL] [Abstract][Full Text] [Related]
54. Gender effects on intramuscular interferon beta-1a in relapsing-remitting multiple sclerosis: analysis of 1406 patients.
Rudick RA; Kappos L; Kinkel R; Clanet M; Phillips JT; Herndon RM; Sandrock AW; Munschauer FE
Mult Scler; 2011 Mar; 17(3):353-60. PubMed ID: 20965959
[TBL] [Abstract][Full Text] [Related]
55. MRI brain volume changes in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a.
Gasperini C; Paolillo A; Giugni E; Galgani S; Bagnato F; Mainero C; Onesti E; Bastianello S; Pozzilli C
Mult Scler; 2002 Apr; 8(2):119-23. PubMed ID: 11990868
[TBL] [Abstract][Full Text] [Related]
56. Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability.
Flachenecker P; Reiners K; Krauser M; Wolf A; Toyka KV
Mult Scler; 2001 Oct; 7(5):327-34. PubMed ID: 11724449
[TBL] [Abstract][Full Text] [Related]
57. Effect of dose and frequency of interferon beta-1a administration on clinical and magnetic resonance imaging parameters in relapsing-remitting multiple sclerosis.
Cocco E; Marchi P; Floris G; Mascia MG; Deriu M; Sirca A; Mamusa E; Lai M; Mura M; Mallarini G; Marrosu MG
Funct Neurol; 2006; 21(3):145-9. PubMed ID: 17049133
[TBL] [Abstract][Full Text] [Related]
58. Plasma ubiquitin-proteasome system profile in patients with multiple sclerosis: correlation with clinical features, neuroimaging, and treatment with interferon-beta-1b.
Minagar A; Ma W; Zhang X; Wang X; Zhang K; Alexander JS; Gonzalez-Toledo E; Albitar M
Neurol Res; 2012 Jul; 34(6):611-8. PubMed ID: 22709658
[TBL] [Abstract][Full Text] [Related]
59. Efficacy and safety of subcutaneous interferon-β-1a in patients with a first demyelinating event and early multiple sclerosis.
Freedman MS
Expert Opin Biol Ther; 2014 Aug; 14(8):1207-14. PubMed ID: 24965353
[TBL] [Abstract][Full Text] [Related]
60. Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial.
Togha M; Karvigh SA; Nabavi M; Moghadam NB; Harirchian MH; Sahraian MA; Enzevaei A; Nourian A; Ghanaati H; Firouznia K; Jannati A; Shekiba M
Mult Scler; 2010 Jul; 16(7):848-54. PubMed ID: 20488825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
